Many people know GLP-1 medications for their role in weight management, but research now shows that these therapies may also support blood sugar control, cardiovascular health, inflammation reduction, longevity, cognition, and metabolic health
[1] Researchers report that the peptide exhibited equivalent or better performance using two recombinant CHO cell lines. IGF-1 LR3 may be more capable of inducing the type 1 IGF receptor, potentially promoting an elevated level of intracellular signaling, cellular proliferation, and apoptosis inhibition
The formulations also were posited to be impactful when tested alongside agents that may be associated with alopecia
"Evaluation of antioxidant treatment in presbyacusis." J Laryngol Otol
Why Compounded GLP-1 Medications Cost Less Than Brand Names Compounded medications bypass expensive marketing budgets, patent protections, and retail distribution networks that inflate brand-name drug costs
The role of hypothalamic estrogen receptors in metabolic regulation